Turalio 125MG, 120CT JAN FY26 $22,061.05
Ended Awarded Last action
- Contract number
- 15B50526F00000031
- Awardee
-
Daiichi Sankyo, Inc. UEI YUKQY5G72Q29
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $22,725
Award facts
- Contract value 100% obligated
- $22,725.09 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Basking Ridge, Bernards, NJ, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $664 | |
| Original award | $22,061 |
About this award
This delivery order awards $22.73M to Daiichi Sankyo, Inc. for the supply of TURALIO (pexidartinib) 125mg capsules in 120-count bottles, with an ultimate completion date of January 31, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and funded by Federal Medical Center Carswell, a civilian facility within the Department of Veterans Affairs. Daiichi Sankyo will perform the delivery order from its headquarters location in Basking Ridge, New Jersey, serving VA healthcare facilities within Veterans Integrated Service Networks 20 and 22.
This delivery order is placed against a single-award Blanket Purchase Agreement established between Daiichi Sankyo and the VA National Acquisition Center on May 22, 2025, valued at $80.21M and effective through May 21, 2026 with four optional one-year renewal periods. TURALIO is a specialized medication indicated for the treatment of tenosynovial giant cell tumor, a rare musculoskeletal condition, and the BPA structure provides VA medical centers streamlined access to both 125mg and 200mg dosages on an as-needed basis without requiring individual competitive solicitations. Daiichi Sankyo operates as the prime contractor with no documented subcontractors, and the BPA incorporates firm fixed pricing mechanisms and 2026 Public Law updates to maintain budgetary control while accommodating variable ordering volumes across the participating Veterans Integrated Service Networks.
Quick answers
Who was awarded contract 15B50526F00000031?
15B50526F00000031 was awarded to Daiichi Sankyo, Inc. by Federal Medical Center Carswell (Correctional Facilities) on January 31, 2026.
How much is contract 15B50526F00000031 worth?
The government has obligated $22,725 on 15B50526F00000031.
Is contract 15B50526F00000031 an order under another contract?
Yes. 15B50526F00000031 is a delivery order under 36F79718D0403, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000031 competed?
The extent of competition for 15B50526F00000031 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award